Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice

被引:71
|
作者
Rault-Nania, Marie-Helene
Gueux, Elyett
Demougeot, Celine
Demigne, Christian
Rock, Edmond
Mazur, Andrzej [1 ]
机构
[1] INRA, Ctr Rech Nutr Humaine Auvergne, Unite Nutr Humaine, UMR1019, F-63122 St Genes Champanelle, France
[2] Lab Physiol & Pharmacol, Fac Med & Pharm, Besancon, France
关键词
inulin; oligofructose; apolipoprotein E-deficient mice; atherosclerosis;
D O I
10.1017/BJN20061913
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Effects of different inulin-type fructan fractions were studied on atherosclerotic plaque formation in male apo E-deficient mice. Thirty-two mice were randomly divided into four groups and received either a semi-purified sucrose-based diet (control group), or diets in which sucrose was replaced in part by various inulin-type fructans (10 g/100 g): long-chain inulin, oligofructose, or an oligofructose-enriched inulin for 16 weeks. The presence of atherosclerotic plaques was assessed by histomorphometry in the aortic sinus. The apo E-deficient mice fed long-chain inulin or an oligofructose-enriched inulin had about 35 % and 25 % less atherosclerotic lesion area compared with the control group, respectively. Feeding long-chain inulin significantly reduced plasma cholesterol concentrations (P < 0.001), and the three inulin-type fructans reduced triacylglycerol (TAG) concentrations compared with the control group (P < 0.001). Both the long-chain inulin and an oligofructose-enriched inulin significantly lowered hepatic cholesterol concentrations compared with the control diet (P < 0.05). Hepatic TAG concentrations were significantly lower in all three groups fed the fructan-supplemented diets v. the control group (P < 0.0001). The results of the present study suggest that inhibition of atherosclerotic plaque formation is more potent in the presence of long-chain inulin, either alone or in combination with oligofructose (an oligofructose-enriched inulin), and that this probably is related to changes in lipid metabolism.
引用
收藏
页码:840 / 844
页数:5
相关论文
共 50 条
  • [1] Mast Cell Deficiency Attenuates Atherosclerosis in Apolipoprotein E-deficient mice
    Smith, Donald D.
    Tan, Xiaoyu
    Tawfik, Ossama
    Stechschulte, Daniel J.
    Dileepan, Kottarappat N.
    FASEB JOURNAL, 2008, 22
  • [2] The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice
    Paul, A
    Calleja, L
    Camps, J
    Osada, J
    Vilella, E
    Ferré, NL
    Mayayo, E
    Joven, J
    LIFE SCIENCES, 2000, 68 (04) : 457 - 465
  • [3] Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice
    Matsui, Y
    Rittling, SR
    Okamoto, H
    Inobe, M
    Jia, N
    Shimizu, T
    Akino, M
    Sugawara, T
    Morimoto, J
    Kimura, C
    Kon, S
    Denhardt, D
    Kitabatake, A
    Uede, T
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (06) : 1029 - 1034
  • [4] Diet and Atherosclerosis in Apolipoprotein E-Deficient Mice
    Imaizumi, Katsumi
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2011, 75 (06) : 1023 - 1035
  • [5] Therapy of Atherosclerosis in Apolipoprotein E-Deficient Mice
    Wang, Min
    Yang, Hua
    Tan, Mengqun
    MOLECULAR THERAPY, 2014, 22 : S231 - S231
  • [6] Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice
    Shamir, R
    Shehadeh, N
    Rosenblat, M
    Eshach-Adiv, O
    Coleman, R
    Kaplan, M
    Hamoud, S
    Lischinsky, S
    Hayek, T
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (01) : 104 - 110
  • [7] Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice
    Hishikawa, K
    Nakaki, T
    Fujita, T
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (02) : 442 - 446
  • [8] Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice
    Okamoto, Y
    Kihara, S
    Ouchi, N
    Nishida, M
    Arita, Y
    Kumada, M
    Ohashi, K
    Sakai, N
    Shimomura, I
    Kobayashi, H
    Terasaka, N
    Inaba, T
    Funahashi, T
    Matsuzawa, Y
    CIRCULATION, 2002, 106 (22) : 2767 - 2770
  • [9] Digoxin reduces atherosclerosis in apolipoprotein E-deficient mice
    Shi, Huairui
    Mao, Xiaobo
    Zhong, Yucheng
    Liu, Yuzhou
    Zhao, Xiaoqi
    Yu, Kunwu
    Zhu, Ruirui
    Wei, Yuzhen
    Zhu, Jianghao
    Sun, Haitao
    Mao, Yi
    Zeng, Qiutang
    BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (09) : 1517 - 1528
  • [10] Overexpression of CTRP9 attenuates the development of atherosclerosis in apolipoprotein E-deficient mice
    Chengmin Huang
    Peng Zhang
    Tingting Li
    Jun Li
    Tianjiao Liu
    Anju Zuo
    Jiying Chen
    Yuan Guo
    Molecular and Cellular Biochemistry, 2019, 455 : 99 - 108